AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,538 | -3.2% | 7,610 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $95,582 | +112349.4% | 7,610 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $85 | -8.6% | 7,630 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $93 | -99.9% | 7,630 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $77,000 | -3.8% | 7,630 | +2.6% | 0.00% | 0.0% |
| Q2 2022 | $80,000 | -1.2% | 7,440 | -13.3% | 0.00% | 0.0% |
| Q1 2022 | $81,000 | -6.9% | 8,580 | -7.6% | 0.00% | 0.0% |
| Q4 2021 | $87,000 | -14.7% | 9,290 | -13.4% | 0.00% | 0.0% |
| Q3 2021 | $102,000 | -1.0% | 10,730 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $103,000 | +329.2% | 10,730 | +341.6% | 0.00% | – |
| Q1 2021 | $24,000 | -90.0% | 2,430 | -76.5% | 0.00% | -100.0% |
| Q4 2020 | $239,000 | +89.7% | 10,330 | +15.7% | 0.00% | +100.0% |
| Q3 2020 | $126,000 | +306.5% | 8,930 | +339.9% | 0.00% | – |
| Q2 2020 | $31,000 | +82.4% | 2,030 | +11.5% | 0.00% | – |
| Q1 2020 | $17,000 | -46.9% | 1,820 | -44.3% | 0.00% | – |
| Q4 2019 | $32,000 | +190.9% | 3,270 | +145.9% | 0.00% | – |
| Q3 2019 | $11,000 | 0.0% | 1,330 | +44.6% | 0.00% | – |
| Q2 2019 | $11,000 | -15.4% | 920 | 0.0% | 0.00% | – |
| Q1 2019 | $13,000 | +44.4% | 920 | 0.0% | 0.00% | – |
| Q4 2018 | $9,000 | -18.2% | 920 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | -50.0% | 920 | -34.8% | 0.00% | – |
| Q2 2018 | $22,000 | +22.2% | 1,410 | +17.5% | 0.00% | – |
| Q1 2018 | $18,000 | -25.0% | 1,200 | -27.7% | 0.00% | – |
| Q4 2017 | $24,000 | -4.0% | 1,660 | 0.0% | 0.00% | – |
| Q3 2017 | $25,000 | +47.1% | 1,660 | 0.0% | 0.00% | – |
| Q2 2017 | $17,000 | +142.9% | 1,660 | +72.9% | 0.00% | – |
| Q1 2017 | $7,000 | -22.2% | 960 | -46.7% | 0.00% | – |
| Q4 2016 | $9,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |